Weight-loss drug Zepbound helped drive Ireland to $76 billion in goods exports to the U.S. last year—a bittersweet reminder of the challenges ahead
Ireland's pharmaceutical industry shipped billions' worth of goods to the U.S., but face threats from Trump 2.0.
pharmaphorum17h
3rd Obesity & Weight Loss Summit
The 3rd Obesity & Weight Loss Drug Development Summit is the place to be for experts in weight loss drug development tackling ...
Retratutide: A New Dawn in the Treatment of Obesity and Type 2 Diabetes
Byline: Hank Popeil In the ever-evolving landscape of healthcare, groundbreaking innovations are not merely celebrated for their scientific ingenuity but for their potential to radically improve human ...
Le Lézard17h
Lilly to participate in TD Cowen's 45th Annual Health Care Conference
Eli Lilly and Company will participate in TD Cowen's 45th Annual Health Care Conference on March 4, 2025. Jake Van Naarden, executive vice president and president, Lilly Oncology, will take part in a ...
The Zacks Analyst Blog Highlights Apple, Eli Lilly, Shopify and ImmuCell
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...
Le Lézard19h
TransCelerate BioPharma Releases 2024 Annual Report, Highlights Strategic Vision and Announces Board Leadership Transition
TransCelerate BioPharma (TransCelerate), a global nonprofit organization dedicated to improving the health of patients by accelerating and simplifying the clinical R&D process, has released its 2024 ...
Altimmune's Catalytic Moment In 2025: Pemvidutide's Phase 2b Trial In MASH
Altimmune's existence depends almost entirely on the outcome of the Phase 2 trial for pemvidutide in MASH. Learn why ALT ...